Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study

Aim: To report on visual outcome of patients receiving an intravitreal injection of triamcinolone acetonide for treatment of diffuse diabetic macular oedema. Methods: Prospective, comparative, non-randomised clinical interventional study included 136 patients with diffuse diabetic macular oedema. Pa...

Full description

Saved in:
Bibliographic Details
Published in:British journal of ophthalmology 2005-03, Vol.89 (3), p.321-326
Main Authors: Jonas, J B, Akkoyun, I, Kreissig, I, Degenring, R F
Format: Article
Language:English
Subjects:
Age
Aged
Anti-Inflammatory Agents - administration & dosage
Anti-Inflammatory Agents - therapeutic use
Biological and medical sciences
Cataracts
Chi-Square Distribution
Clinical Science - Extended Reports
Diabetes
diabetes mellitus
Diabetes Mellitus - drug therapy
Diabetes Mellitus - physiopathology
Diabetes Mellitus - surgery
Diabetes. Impaired glucose tolerance
diabetic macular oedema
Diabetic retinopathy
Early Treatment Diabetic Retinopathy Study
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
ETDRS
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Female
Follow-Up Studies
Glaucoma
Humans
Injections
intraocular pressure
intravitreal medication
IOP
Laser Therapy
Macular Degeneration - drug therapy
Macular Degeneration - physiopathology
Macular Degeneration - surgery
Male
Medical sciences
Middle Aged
Prospective Studies
Standard deviation
Statistics, Nonparametric
Studies
triamcinolone acetonide
Triamcinolone Acetonide - administration & dosage
Triamcinolone Acetonide - therapeutic use
Visual Acuity
Vitreous Body
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim: To report on visual outcome of patients receiving an intravitreal injection of triamcinolone acetonide for treatment of diffuse diabetic macular oedema. Methods: Prospective, comparative, non-randomised clinical interventional study included 136 patients with diffuse diabetic macular oedema. Patients of the study group (97 eyes) received an intravitreal injection of 20–25 mg of triamcinolone acetonide and no other retinal treatment. Patients of the control group (69 eyes) received focal or panretinal laser treatment if indicated. Mean (standard deviation) follow up was 8.4 (SD 6.0) months (range 1.03–25.2 months). Results: Visual acuity (VA) increased significantly (p
ISSN:0007-1161
1468-2079
DOI:10.1136/bjo.2004.046391